MedPath

A Study to evaluate the efficacy of Guda Haritaki in prevention of Pratishyaya w.s.r to Rhinitis in childre

Phase 2
Registration Number
CTRI/2023/07/055321
Lead Sponsor
Dr Mahitha V
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Healthy children in the age group between 3-6 years, irrespective of the religion, gender,

and socio-economic status will be included.

2) Children with a history of 1 or more episodes of Rhinitis per month in past 3 months or more

than 6 episodes per year will be included.

3) Children whose parents are willing to sign the written consent form and follow the protocol

will be included

Exclusion Criteria

1) Children less than 3 years and more than 6 years of age will be excluded.

2) Children with the history of Nasal polyps, Deviated Nasal Septum, Bronchial asthma,

Pertussis, Tuberculosis, COPD, Bronchiectasis, Tropical eosinophilia, cerebrospinal fluid

rhinorrhoea, and other systemic illness and those who are on regular medication will be

excluded.

3) Children with Rhinitis secondary to Lupus, Diphtheria, Syphilis etc. will be excluded.

4) Children with Congenital anomalies of Respiratory and Cardiovascular system will be

excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of improvement in the composite overall important symptoms like <br/ ><br>1)Nasal congestion <br/ ><br>2)watery eyes <br/ ><br>3)sore throat <br/ ><br>4)sneezing <br/ ><br>5) headache etc <br/ ><br>and its intensity & frequency of recurrence in rhinitis attacks.Timepoint: Before intervention - 0th day <br/ ><br>During intervention - 30th day, 60th day <br/ ><br>After intervention - 75th day, 90th day
Secondary Outcome Measures
NameTimeMethod
Assessment of the improvement in recurrent rhinitis by Rhinitis Control Assessment Test (RCAT) & Pratishyaya Severity Scale in ChildrenTimepoint: Before intervention - 0th day <br/ ><br>During intervention - 30th day, 60th day <br/ ><br>After intervention - 75th day, 90th day
© Copyright 2025. All Rights Reserved by MedPath